Thousands of patients to benefit as NHS marks 100th fast tracked cancer drug

NHS England

14 July 2022 - Thousands of people a year with advanced breast cancer will benefit from a life extending drug that has been fast-tracked onto the frontline of NHS patient care.

The drug, alpelisib, will be used in combination with the hormone therapy, fulvestrant, to target the gene that causes fast growing tumours.

Read NHS England press release

Michael Wonder

Posted by:

Michael Wonder